Question of the Day August 24, 2013 Does Congress, both the House and the Senate, Need to Put More Research and Time into Making the Compounding Legislation the Best Possible Fix for What is now Clearly a Multi-Layer, Multi-Wide Problem?

The multi-layer. multi-wide issues include both  ANIMAL and HUMAN compounded drugs, problems with the raw or bulk chemicals and where they are coming from, the testing being done on them, the actual compounding facilities and the procedures there, and now the laboratory testing facilities that test for sterility, potency, etc.

Are do readers think it is better to go ahead and pass a bill  giving the FDA authority and then tweak and amended it as more information comes to light?